Clinical trial
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158
Study timeline
Study start (actual)2020-11-01Date precision: day
Registry last updated2022-11-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Progression, Diseaseunresolved
Interventions
MRIDIAGNOSTIC_TEST
Sponsors & collaborators
University of Nottinghamlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05631158 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.